JP2006516272A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006516272A5 JP2006516272A5 JP2006500187A JP2006500187A JP2006516272A5 JP 2006516272 A5 JP2006516272 A5 JP 2006516272A5 JP 2006500187 A JP2006500187 A JP 2006500187A JP 2006500187 A JP2006500187 A JP 2006500187A JP 2006516272 A5 JP2006516272 A5 JP 2006516272A5
- Authority
- JP
- Japan
- Prior art keywords
- fentanyl
- composition according
- composition
- pectin
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims description 27
- 229960002428 fentanyl Drugs 0.000 claims description 26
- 229920001277 pectin Polymers 0.000 claims description 17
- 239000001814 pectin Substances 0.000 claims description 17
- 235000010987 pectin Nutrition 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 208000002193 Pain Diseases 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 230000032050 esterification Effects 0.000 claims description 6
- 238000005886 esterification reaction Methods 0.000 claims description 6
- 229910021645 metal ion Inorganic materials 0.000 claims description 6
- 230000036470 plasma concentration Effects 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 208000000094 Chronic Pain Diseases 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- IVLVTNPOHDFFCJ-UHFFFAOYSA-N fentanyl citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 IVLVTNPOHDFFCJ-UHFFFAOYSA-N 0.000 claims 16
- 238000000034 method Methods 0.000 claims 3
- 239000007921 spray Substances 0.000 claims 2
- 229960004207 fentanyl citrate Drugs 0.000 claims 1
- 239000012458 free base Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000282412 Homo Species 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0300531.1 | 2003-01-10 | ||
| GBGB0300531.1A GB0300531D0 (en) | 2003-01-10 | 2003-01-10 | Pharmaceutical compositions |
| PCT/GB2004/000057 WO2004062561A2 (en) | 2003-01-10 | 2004-01-12 | Pharmaceutical compositions comprising fentanyl for intranasal delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006516272A JP2006516272A (ja) | 2006-06-29 |
| JP2006516272A5 true JP2006516272A5 (enExample) | 2011-07-28 |
| JP4827725B2 JP4827725B2 (ja) | 2011-11-30 |
Family
ID=9950919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006500187A Expired - Fee Related JP4827725B2 (ja) | 2003-01-10 | 2004-01-12 | 医薬品組成物 |
Country Status (25)
| Country | Link |
|---|---|
| US (5) | US20040166067A1 (enExample) |
| EP (2) | EP1635783B1 (enExample) |
| JP (1) | JP4827725B2 (enExample) |
| KR (3) | KR20100118144A (enExample) |
| CN (1) | CN100423709C (enExample) |
| AU (1) | AU2004204381B2 (enExample) |
| BR (1) | BRPI0406674B8 (enExample) |
| CA (1) | CA2511974C (enExample) |
| CY (1) | CY1115056T1 (enExample) |
| DK (1) | DK1635783T5 (enExample) |
| EA (1) | EA008500B1 (enExample) |
| ES (2) | ES2432119T3 (enExample) |
| FR (1) | FR14C0020I1 (enExample) |
| GB (1) | GB0300531D0 (enExample) |
| GE (1) | GEP20084340B (enExample) |
| IL (1) | IL169480A (enExample) |
| MX (1) | MXPA05007333A (enExample) |
| NO (1) | NO335127B1 (enExample) |
| NZ (1) | NZ541018A (enExample) |
| PL (1) | PL212950B1 (enExample) |
| PT (2) | PT2436375T (enExample) |
| SI (1) | SI1635783T1 (enExample) |
| UA (1) | UA85050C2 (enExample) |
| WO (1) | WO2004062561A2 (enExample) |
| ZA (1) | ZA200505274B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1307194T2 (sl) * | 2000-07-31 | 2011-07-29 | Nycomed Danmark Aps | Sestavek fentanila za nazalno dejanje |
| US7666876B2 (en) * | 2002-03-19 | 2010-02-23 | Vernalis (R&D) Limited | Buprenorphine formulations for intranasal delivery |
| GB0300531D0 (en) | 2003-01-10 | 2003-02-12 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
| GB0315632D0 (en) | 2003-07-04 | 2003-08-13 | West Pharm Serv Drug Res Ltd | Pharmaceutical formulations |
| US20050129679A1 (en) | 2003-12-15 | 2005-06-16 | Nastech Pharmaceutical Company Inc. | Method for opening tight junctions |
| EP2057982A1 (en) | 2007-11-09 | 2009-05-13 | Archimedes Development Limited | Intranasal compositions |
| GB2464282A (en) * | 2008-10-08 | 2010-04-14 | Archimedes Dev Ltd | A device for administering a dose of opioid analgesic |
| CZ302789B6 (cs) | 2009-11-25 | 2011-11-09 | Zentiva, K. S. | Zpusob zvýšení rozpustnosti farmaceuticky aktivních látek a cílený (kontrolovaný) transport do streva |
| PT2670674T (pt) | 2011-02-04 | 2016-09-21 | Archimedes Dev Ltd | Recipiente aprimorado |
| SG194927A1 (en) | 2011-05-13 | 2013-12-30 | Euro Celtique Sa | Intranasal pharmaceutical dosage forms comprising naloxone |
| WO2014053592A1 (en) | 2012-10-03 | 2014-04-10 | Proponent Biotech Gmbh | Esters of short chains fatty acids for use in the treatment of immunogenic disorders |
| KR102512797B1 (ko) | 2013-09-05 | 2023-03-22 | 에이비2 바이오 에스에이 | 염증성 질환에서 il-18 결합 단백질(ｉｌ-18ｂｐ) |
| US11135155B2 (en) | 2014-07-08 | 2021-10-05 | Hikma Pharmaceuticals Usa Inc. | Liquid naloxone spray |
| SG11201706879UA (en) | 2015-03-05 | 2017-09-28 | Ab2 Bio Sa | Il-18 binding protein (il-18bp) and antibodies in inflammatory diseases |
| US9650338B1 (en) | 2016-07-29 | 2017-05-16 | VDM Biochemicals, Inc. | Opioid antagonist compounds and methods of making and using |
| WO2018130948A1 (en) * | 2017-01-11 | 2018-07-19 | Torrent Pharmaceuticals Limited | Tapentadol nasal composition |
| US11207309B2 (en) | 2019-07-19 | 2021-12-28 | Hikma Pharmaceuticals International Limited | Ready-to-administer fentanyl formulations |
| US11160799B2 (en) * | 2019-10-22 | 2021-11-02 | Cessatech A/S | Pediatric combination |
| CN111272860B (zh) | 2020-03-16 | 2022-11-25 | 中国检验检疫科学研究院 | 一种芬太尼类物质的小型便携式质谱现场快速检测方法 |
| EP4146174A1 (en) | 2020-05-06 | 2023-03-15 | AB2 Bio SA | Il-18 binding protein (il-18bp) in respiratory diseases |
| GB202007404D0 (en) | 2020-05-19 | 2020-07-01 | Nasser Syed Muhammad Tahir | Treatment for viral respiratory infections |
| EP3943097A1 (en) | 2020-07-24 | 2022-01-26 | AB2 Bio SA | Car-t cell therapy |
| WO2023067348A1 (en) | 2021-10-21 | 2023-04-27 | Biosirius Ltd | Treatment for virally-induced pneumonia |
| EP4486367A1 (en) | 2022-03-04 | 2025-01-08 | AB2 Bio SA | Il-18 binding protein (il-18bp) in the treatment of vexas |
Family Cites Families (93)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2125212A (en) * | 1938-05-03 | 1938-07-26 | Vick Chemical Company | Therapeutic composition |
| US2730483A (en) * | 1952-08-12 | 1956-01-10 | Nepera Chemical Co Inc | Therapeutic compositions comprising neomycin, gramicidin and quaternary ammonium salt of thonzylamine |
| BE623427A (enExample) * | 1961-10-10 | |||
| US3184600A (en) | 1963-05-07 | 1965-05-18 | Potter Instrument Co Inc | Photosensitive apparatus for measuring coordinate distances |
| JPS5885813A (ja) * | 1981-11-17 | 1983-05-23 | Toyo Jozo Co Ltd | 吸収性良好な製剤 |
| US4464378A (en) * | 1981-04-28 | 1984-08-07 | University Of Kentucky Research Foundation | Method of administering narcotic antagonists and analgesics and novel dosage forms containing same |
| US4659696A (en) * | 1982-04-30 | 1987-04-21 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition and its nasal or vaginal use |
| JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
| US4486423A (en) * | 1983-04-21 | 1984-12-04 | Janssen Pharmaceutica Inc. | Stable fentanyl composition |
| US4806341A (en) * | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
| US5122127A (en) | 1985-05-01 | 1992-06-16 | University Of Utah | Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues |
| HU193780B (en) * | 1985-06-21 | 1987-11-30 | Richter Gedeon Vegyeszet | Process for producing 2-halogeno-6-methyl-ergol-9-ene derivatives and acid additional salts thereof |
| FR2588189B1 (fr) * | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| JPS62123112A (ja) * | 1985-11-22 | 1987-06-04 | Sunstar Inc | 軟膏基剤 |
| DE3601132A1 (de) | 1986-01-16 | 1987-07-23 | Christian Bannert | Verfahren zur behandlung der schleimhaut |
| JPS62236862A (ja) | 1986-04-09 | 1987-10-16 | Nippon Kayaku Co Ltd | 人工粘液 |
| ZA875317B (en) | 1986-08-01 | 1988-01-25 | Warner-Lambert Company | Transdermal compositions |
| ATE77559T1 (de) | 1986-11-14 | 1992-07-15 | Theratech Inc | Erhoehung des penetrationsvermoegens mittels eines aus die zellhuelle veraendernden substanzen und kurzkettigen alkoholen bestehenden binaeren systems. |
| US4826683A (en) * | 1987-01-09 | 1989-05-02 | Bates Harry L | Decongestant |
| US5200180A (en) * | 1987-06-26 | 1993-04-06 | Christian Bannert | Pharmaceutical composition for the treatment of the human eye |
| DE3726797A1 (de) * | 1987-08-12 | 1989-02-23 | Bayer Ag | Arzneimittel fuer den bereich der mundhoehle |
| US4915948A (en) | 1987-08-31 | 1990-04-10 | Warner-Lambert Company | Tablets having improved bioadhesion to mucous membranes |
| US5457093A (en) * | 1987-09-18 | 1995-10-10 | Ethicon, Inc. | Gel formulations containing growth factors |
| DE3827561C1 (enExample) * | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
| US5236714A (en) * | 1988-11-01 | 1993-08-17 | Alza Corporation | Abusable substance dosage form having reduced abuse potential |
| GB8900267D0 (en) | 1989-01-06 | 1989-03-08 | Riker Laboratories Inc | Narcotic analgesic formulations and apparatus containing same |
| GB8904370D0 (en) | 1989-02-25 | 1989-04-12 | Cosmas Damian Ltd | Liquid delivery compositions |
| JP2911496B2 (ja) * | 1989-09-11 | 1999-06-23 | 帝國製薬株式会社 | 生理活性ポリペプチド含有高吸収性経膣剤 |
| US5707644A (en) * | 1989-11-04 | 1998-01-13 | Danbiosyst Uk Limited | Small particle compositions for intranasal drug delivery |
| GB2237510B (en) | 1989-11-04 | 1993-09-15 | Danbiosyst Uk | Small particle drug compositions for nasal administration |
| NL9000634A (nl) | 1990-03-20 | 1991-10-16 | Catharina Ziekenhuis Stichting | Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding. |
| US5397771A (en) * | 1990-05-10 | 1995-03-14 | Bechgaard International Research And Development A/S | Pharmaceutical preparation |
| US5346703A (en) * | 1990-08-07 | 1994-09-13 | Mediventures, Inc. | Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
| EP0491076A1 (en) | 1990-12-19 | 1992-06-24 | Theratech, Inc. | Penetration enhancement with multi-component system of N-aliphatic pyrrolidones with lower alcohols |
| JPH0597706A (ja) | 1991-04-09 | 1993-04-20 | Chemex Block Drug Jv | アフタ性潰瘍および他の粘膜皮膚障害の処置方法 |
| US5318780A (en) * | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
| US5266331A (en) | 1991-11-27 | 1993-11-30 | Euroceltique, S.A. | Controlled release oxycodone compositions |
| GB9202464D0 (en) | 1992-02-05 | 1992-03-18 | Danbiosyst Uk | Composition for nasal administration |
| DE69222295T2 (de) | 1992-05-26 | 1998-04-09 | The Procter & Gamble Co., Cincinnati, Ohio | Pulverförmige pharmazeutische Zusammensetzung |
| ATE225646T1 (de) | 1992-07-23 | 2002-10-15 | Hisamitsu Pharmaceutical Co | Perkutan verabreichbare basiszusammensetzung und daraus hergestellte zusammensetzung |
| WO1994010987A1 (en) | 1992-11-09 | 1994-05-26 | Pharmetrix Corporation | Combined analgesic delivery methods for pain management |
| US5507277A (en) * | 1993-01-29 | 1996-04-16 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activateddispenser |
| US5756483A (en) | 1993-03-26 | 1998-05-26 | Merkus; Franciscus W. H. M. | Pharmaceutical compositions for intranasal administration of apomorphine |
| GB9310412D0 (en) | 1993-05-20 | 1993-07-07 | Danbiosyst Uk | Nasal nicotine system |
| SE9301877D0 (sv) | 1993-06-02 | 1993-06-02 | Kabi Pharmacia Ab | In situ gel for therapeutic use |
| BR9407397A (pt) | 1993-07-12 | 1996-11-05 | Virus Res Inst | Vacinas microencapsuladas em hidrogel |
| US5422116A (en) | 1994-02-18 | 1995-06-06 | Ciba-Geigy Corporation | Liquid ophthalmic sustained release delivery system |
| US5543434A (en) * | 1994-02-25 | 1996-08-06 | Weg; Stuart L. | Nasal administration of ketamine to manage pain |
| GB9406171D0 (en) * | 1994-03-29 | 1994-05-18 | Electrosols Ltd | Dispensing device |
| ES2135723T3 (es) * | 1994-03-30 | 1999-11-01 | Gs Dev Ab | Uso de esteres de acidos grasos como sustancias bioadhesivas. |
| DE69528165T2 (de) | 1994-04-21 | 2003-05-15 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal verabreichbare grundlage und daraus hergestelltes transdermal verabreichbares arzneimittel |
| WO1995031182A1 (en) * | 1994-05-13 | 1995-11-23 | Aradigm Corporation | Narcotic containing aerosol formulation |
| GB9414966D0 (en) | 1994-07-26 | 1994-09-14 | Danbiosyst Uk | Pharmaceutical compositions for the nasal administration of antiviral agents |
| FR2733420B1 (fr) | 1995-04-28 | 1997-06-27 | Sep Tarral | Preparations pectiques utilisables comme support de medicament |
| US6881208B1 (en) | 1995-06-05 | 2005-04-19 | Joseph B. Phipps | Method and device for transdermal electrotransport delivery of fentanyl and sufentanil |
| IE960375A1 (en) | 1995-06-05 | 1996-12-11 | Alza Corp | Device for transdermal electrotransport delivery of fentanyl¹and sufentanil |
| CN1147329C (zh) | 1995-06-05 | 2004-04-28 | 阿尔萨公司 | 用于经皮肤电输送芬太尼和苏芬太尼的装置 |
| JP3098401B2 (ja) | 1995-07-12 | 2000-10-16 | 株式会社エルティーティー研究所 | 経鼻投与用製剤 |
| DE19527411A1 (de) * | 1995-07-27 | 1997-01-30 | Ackermann & Schmitt Gmbh & Co | Kupplung |
| US5840731A (en) | 1995-08-02 | 1998-11-24 | Virginia Commonwealth University | Pain-alleviating drug composition and method for alleviating pain |
| IL127956A0 (en) | 1996-07-11 | 1999-11-30 | Farmarc Nederland Bv | Inclusion complex containing indole selective serotonin agonist |
| US6667279B1 (en) | 1996-11-13 | 2003-12-23 | Wallace, Inc. | Method and composition for forming water impermeable barrier |
| US6126919A (en) | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
| GB9707934D0 (en) * | 1997-04-18 | 1997-06-04 | Danbiosyst Uk | Improved delivery of drugs to mucosal surfaces |
| GB2328443B (en) | 1997-08-21 | 2001-09-05 | Reckitt & Colmann Prod Ltd | In situ formation of pharmaceutically acceptable polymeric material |
| RS49982B (sr) | 1997-09-17 | 2008-09-29 | Euro-Celtique S.A., | Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2 |
| DE69831421T2 (de) | 1997-12-02 | 2006-06-22 | Archimedes Development Ltd. | Zusammensetzungen zur nasalen verabreichung |
| US6090368A (en) | 1998-03-03 | 2000-07-18 | The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations | Pharmaceutical compositions for intranasal spray administration of ketorolac tromethamine |
| US6007841A (en) | 1998-03-13 | 1999-12-28 | Algos Pharmaceutical Corporation | Analgesic composition and method for treating pain |
| AU5305899A (en) | 1998-08-26 | 2000-03-21 | Teijin Limited | Powdery pernasal compositions |
| SE9803239D0 (sv) | 1998-09-24 | 1998-09-24 | Diabact Ab | Composition for the treatment of acute pain |
| SE9803240D0 (sv) | 1998-09-24 | 1998-09-24 | Diabact Ab | A pharmaceutical composition having a rapid action |
| GB9823246D0 (en) | 1998-10-24 | 1998-12-16 | Danbiosyst Uk | A nasal drug delivery composition |
| JP2000229859A (ja) | 1999-02-12 | 2000-08-22 | Teijin Ltd | 安定なブプレノルフィン経鼻製剤 |
| WO2000047203A1 (en) | 1999-02-12 | 2000-08-17 | Mqs, Inc. | Formulation and system for intra-oral delivery of pharmaceutical agents |
| US6541021B1 (en) | 1999-03-18 | 2003-04-01 | Durect Corporation | Devices and methods for pain management |
| WO2001068140A2 (en) | 2000-03-10 | 2001-09-20 | Durect Corporation | Opioid formulations |
| JP2001002589A (ja) | 1999-06-18 | 2001-01-09 | Teijin Ltd | 穏やかな薬物血中濃度の上昇を可能とする経鼻投与用組成物 |
| CA2381860C (en) * | 1999-08-26 | 2009-11-24 | Takeda Chemical Industries, Ltd. | Matrix adhering to nasal mucosa |
| JP2001089359A (ja) | 1999-09-24 | 2001-04-03 | Toko Yakuhin Kogyo Kk | 鎮痛成分の点鼻用ゲルまたはゾル製剤 |
| GB9924797D0 (en) * | 1999-10-20 | 1999-12-22 | West Pharm Serv Drug Res Ltd | Compound |
| AR031682A1 (es) | 1999-11-19 | 2003-10-01 | Reckitt Benckiser Helthcare Uk | Composiciones farmaceuticas |
| EP2517710B1 (en) | 2000-02-08 | 2015-03-25 | Euro-Celtique S.A. | Tamper-resistant oral opioid agonist formulations |
| AU2001262992A1 (en) | 2000-05-10 | 2002-02-18 | University Of Kentucky Research Foundation | System and method for intranasal administration of opioids |
| US6610271B2 (en) | 2000-05-10 | 2003-08-26 | University Of Kentucky Research Foundation | System and method for intranasal administration of lorazepam |
| WO2001097780A2 (en) | 2000-06-22 | 2001-12-27 | Pharmasol Ltd | Pharmaceutical compositions comprising an opioid analgesic |
| US20020013331A1 (en) * | 2000-06-26 | 2002-01-31 | Williams Robert O. | Methods and compositions for treating pain of the mucous membrane |
| SI1307194T2 (sl) * | 2000-07-31 | 2011-07-29 | Nycomed Danmark Aps | Sestavek fentanila za nazalno dejanje |
| DE10064219B9 (de) | 2000-12-22 | 2009-02-12 | Nasalis Pain Relief International Gmbh | Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung |
| US6777000B2 (en) | 2001-02-28 | 2004-08-17 | Carrington Laboratories, Inc. | In-situ gel formation of pectin |
| GB2378383A (en) | 2001-06-06 | 2003-02-12 | Gursharan Moonga | Nasal delivery of pharmaceutical compositions in powder form |
| US7666876B2 (en) | 2002-03-19 | 2010-02-23 | Vernalis (R&D) Limited | Buprenorphine formulations for intranasal delivery |
| GB0300531D0 (en) | 2003-01-10 | 2003-02-12 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
-
2003
- 2003-01-10 GB GBGB0300531.1A patent/GB0300531D0/en not_active Ceased
-
2004
- 2004-01-08 US US10/753,628 patent/US20040166067A1/en not_active Abandoned
- 2004-01-12 AU AU2004204381A patent/AU2004204381B2/en active Active
- 2004-01-12 DK DK04701381.8T patent/DK1635783T5/da active
- 2004-01-12 KR KR1020107021362A patent/KR20100118144A/ko not_active Abandoned
- 2004-01-12 ES ES04701381T patent/ES2432119T3/es not_active Expired - Lifetime
- 2004-01-12 JP JP2006500187A patent/JP4827725B2/ja not_active Expired - Fee Related
- 2004-01-12 PL PL377823A patent/PL212950B1/pl unknown
- 2004-01-12 BR BRPI0406674A patent/BRPI0406674B8/pt not_active IP Right Cessation
- 2004-01-12 MX MXPA05007333A patent/MXPA05007333A/es active IP Right Grant
- 2004-01-12 EP EP04701381.8A patent/EP1635783B1/en not_active Expired - Lifetime
- 2004-01-12 CA CA2511974A patent/CA2511974C/en not_active Expired - Fee Related
- 2004-01-12 KR KR1020097010700A patent/KR101012148B1/ko not_active Expired - Lifetime
- 2004-01-12 ES ES11185114T patent/ES2721899T3/es not_active Expired - Lifetime
- 2004-01-12 PT PT11185114T patent/PT2436375T/pt unknown
- 2004-01-12 CN CNB200480002000XA patent/CN100423709C/zh not_active Expired - Lifetime
- 2004-01-12 UA UAA200507799A patent/UA85050C2/ru unknown
- 2004-01-12 WO PCT/GB2004/000057 patent/WO2004062561A2/en not_active Ceased
- 2004-01-12 PT PT47013818T patent/PT1635783E/pt unknown
- 2004-01-12 GE GEAP20048931A patent/GEP20084340B/en unknown
- 2004-01-12 SI SI200432094T patent/SI1635783T1/sl unknown
- 2004-01-12 KR KR1020057012821A patent/KR20050103275A/ko not_active Ceased
- 2004-01-12 NZ NZ541018A patent/NZ541018A/en not_active IP Right Cessation
- 2004-01-12 EA EA200501105A patent/EA008500B1/ru not_active IP Right Cessation
- 2004-01-12 EP EP11185114.3A patent/EP2436375B1/en not_active Expired - Lifetime
-
2005
- 2005-06-24 NO NO20053119A patent/NO335127B1/no not_active IP Right Cessation
- 2005-06-29 ZA ZA2005/05274A patent/ZA200505274B/en unknown
- 2005-06-29 IL IL169480A patent/IL169480A/en active IP Right Grant
-
2008
- 2008-03-13 US US12/047,388 patent/US8216604B2/en not_active Expired - Fee Related
-
2012
- 2012-07-03 US US13/541,325 patent/US9078814B2/en not_active Expired - Fee Related
- 2012-07-03 US US13/541,314 patent/US8889176B2/en not_active Expired - Fee Related
-
2013
- 2013-12-04 CY CY20131101096T patent/CY1115056T1/el unknown
-
2014
- 2014-03-13 FR FR14C0020C patent/FR14C0020I1/fr active Active
-
2015
- 2015-06-23 US US14/747,289 patent/US9814705B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006516272A5 (enExample) | ||
| RU2356547C2 (ru) | Способы лечения рака с использованием ингибиторов hdac | |
| JP2021066744A5 (ja) | ブプロピオンおよびデキストロメトルファンを含む組成物 | |
| JP2003512325A (ja) | 感冒およびインフルエンザ様症状の予防並びに治療用組成物、並びにそれらの使用方法 | |
| ES2303645T3 (es) | Composiciones para prevenir y tratar sintomas de tipo resfriado y gripe que comprenden cinc quelado. | |
| CA2511974A1 (en) | Pharmaceutical compositions comprising fentanyl for intranasal delivery | |
| CA2479711A1 (en) | Formulation | |
| JP2005506367A5 (enExample) | ||
| JPH06506472A (ja) | イブプロフェン−鎮咳薬配合物 | |
| JP2003510279A (ja) | 改善された安定性を有する組成物 | |
| KR101862415B1 (ko) | 상승적 항바이러스 조성물 및 이의 용도 | |
| NZ585856A (en) | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease | |
| JP2012162581A (ja) | 経口治療用化合物の供給系 | |
| US20080031959A1 (en) | Anti-migraine oral spray formulations and methods | |
| NZ585857A (en) | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease | |
| CA2671470A1 (en) | Powder formulation for valganciclovir | |
| JP2007506752A (ja) | 肺動脈高血圧症を治療するための併用療法におけるイロプロスト | |
| JP2015214576A (ja) | アセトアミノフェンの治療効果を改善するためのｎ‐アセチルシステイン組成物および方法 | |
| CN1735434A (zh) | 用于预防和治疗伤风与类流感症状的包含精选粘附聚合物的组合物 | |
| JP5403935B2 (ja) | 経口用の慢性疼痛予防または治療剤 | |
| CA2583876A1 (en) | A transmucosal veterinary composition comprising detomidine | |
| JP2006104186A (ja) | 感冒用医薬組成物 | |
| RU2018143564A (ru) | Карбоновая кислота, предназначенная для лечения/предупреждения заложенности носа | |
| JP2003503453A5 (ja) | ガバペンチンおよびプレガバリンを含む相乗作用組成物 | |
| JP5865903B2 (ja) | 経口鉄欠乏療法 |